Internal Medicine Grand Rounds
Beyond Checkpoint Inhibitors: Improving cancer immunotherapy response rates by adding CpG oligonucleotide TLR9 agonists to activate innate immunity by Art Krieg, MD
Individuals with disabilities are encouraged to attend all University of Iowa–sponsored events. If you are a person with a disability who requires a reasonable accommodation in order to participate in this program, please contact Ann Howard in advance at (319)356-4198 or ann-howard@uiowa.edu